Syntec Optics Enables Revolutionary Photonic Biosensing for Accelerated Drug Discovery

ROCHESTER, NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX), a leading provider of mission-critical products to advanced technology defense, biomedical, and communications equipment manufacturers, today announced its continued collaboration to enable development of a novel photonic biosensing technology poised to transform drug discovery and testing. Syntec Optics is providing critical optical manufacturing and sub-assembly processes ...